Home › Funds › Affinity Asset Advisors, LLC › CRSP
Affinity Asset Advisors, LLC position in CRSP
CRISPR THERAPEUTICS AG · Health Care
Affinity Asset Advisors, LLC reported holding 175,000 shares of CRSP (CRISPR THERAPEUTICS AG) in its Q3 2026 13F filing — a position valued at US$9.7M, representing 0.45% of its reported portfolio and ranking #48 among its reported holdings. Affinity Asset Advisors, LLC has disclosed CRSP holdings in 5 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Affinity Asset Advisors, LLC's CRSP position evolved
Affinity Asset Advisors, LLC first disclosed a stake in CRSP in Q1 2024 at 65,000 shares (US$4.4M). The position peaked in Q2 2025 at 200,000 shares, worth US$9.7M. Across 5 filings, Affinity Asset Advisors, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 175,000 shares valued at US$9.7M — an increase of 75,000 shares quarter over quarter.. Notable position changes include a 33% trim in Q2 2026 (shares rose 2% over the following quarter), a 75% increase in Q3 2026 (shares fell 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 65.00K | $4.43M | New |
| Q2 2025 | 200.00K | $9.73M | New |
| Q1 2026 | 150.00K | $7.14M | New |
| Q2 2026 | 100.00K | $5.45M | Reduce |
| Q3 2026 | 175.00K | $9.68M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRSP and 13F data
CRSP (CRISPR THERAPEUTICS AG) is a Health Care company. 30 other funds we track also report a position in CRSP — the largest reported positions include ARK Invest (US$556.3M), Orbis Allan Gray Ltd (US$297.2M), GSK plc (US$144.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRSP
- ARK Invest 10.06M sh · $556.34M · Q3 2026
- Orbis Allan Gray Ltd 5.45M sh · $297.20M · Q2 2026
- GSK plc 2.61M sh · $144.30M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 2.04M sh · $111.19M · Q2 2026
- Amova Asset Management Americas, Inc. 1.45M sh · $80.36M · Q3 2026
- EcoR1 Capital, LLC 1.39M sh · $75.77M · Q2 2026
- NEA Management Company, LLC 1.06M sh · $57.73M · Q2 2026
More on Affinity Asset Advisors, LLC
FAQ
How long has Affinity Asset Advisors, LLC held CRSP?
Affinity Asset Advisors, LLC has disclosed CRSP holdings in 5 of the last 11 reported quarters, going back to Q1 2024.
What is Affinity Asset Advisors, LLC's current position in CRSP?
As of Q3 2026, Affinity Asset Advisors, LLC holds 175.00K shares of CRSP (CRISPR THERAPEUTICS AG), valued at $9.68M, representing 0.45% of its reported portfolio and ranking #48.
Has Affinity Asset Advisors, LLC been buying or selling CRSP?
In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC increased its position in CRSP. The position peaked in Q2 2025 at 200.00K shares.
Which other funds hold CRSP?
Other major institutional holders of CRSP include ARK Invest, Orbis Allan Gray Ltd, GSK plc, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.